Ascom Holding AG (ACMLF)
USD 6.5
(0.0%)
USD 6.5
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | - CHF | -100.0% |
| 2022 | 10 Million CHF | 0.0% |
| 2021 | - CHF | -100.0% |
| 2020 | 19 Million CHF | -52.5% |
| 2019 | 40 Million CHF | 100.0% |
| 2018 | 20 Million CHF | 11.11% |
| 2017 | 18 Million CHF | 76.47% |
| 2016 | 10.2 Million CHF | -49.25% |
| 2015 | 20.1 Million CHF | -33.44% |
| 2014 | 30.2 Million CHF | -50.57% |
| 2013 | 61.1 Million CHF | -41.48% |
| 2012 | 104.4 Million CHF | 496.57% |
| 2011 | 17.5 Million CHF | -76.7% |
| 2010 | 75.1 Million CHF | -25.05% |
| 2009 | 100.2 Million CHF | -47.37% |
| 2008 | 190.4 Million CHF | 6.01% |
| 2007 | 179.6 Million CHF | 179500.0% |
| 2006 | 100 Thousand CHF | -99.94% |
| 2005 | 159.1 Million CHF | -38.71% |
| 2004 | 259.6 Million CHF | 0.0% |
| 2003 | - CHF | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 5 Million CHF | 0.0% |
| 2024 Q2 | 5 Million CHF | 0.0% |
| 2023 Q1 | - CHF | -100.0% |
| 2023 Q2 | - CHF | 0.0% |
| 2023 FY | - CHF | -100.0% |
| 2023 Q4 | - CHF | 0.0% |
| 2023 Q3 | - CHF | 0.0% |
| 2022 Q2 | - CHF | 0.0% |
| 2022 FY | 10 Million CHF | 0.0% |
| 2022 Q1 | - CHF | 0.0% |
| 2022 Q3 | 10 Million CHF | 0.0% |
| 2022 Q4 | 10 Million CHF | 0.0% |
| 2021 FY | - CHF | -100.0% |
| 2021 Q3 | - CHF | 0.0% |
| 2021 Q1 | - CHF | -100.0% |
| 2021 Q2 | - CHF | 0.0% |
| 2021 Q4 | - CHF | 0.0% |
| 2020 Q1 | 28 Million CHF | -30.0% |
| 2020 Q4 | 19 Million CHF | 0.0% |
| 2020 Q3 | 19 Million CHF | -32.14% |
| 2020 FY | 19 Million CHF | -52.5% |
| 2020 Q2 | 28 Million CHF | 0.0% |
| 2019 Q1 | 25 Million CHF | 25.0% |
| 2019 FY | 40 Million CHF | 100.0% |
| 2019 Q3 | 40 Million CHF | 60.0% |
| 2019 Q2 | 25 Million CHF | 0.0% |
| 2019 Q4 | 40 Million CHF | 0.0% |
| 2018 Q1 | 24 Million CHF | 33.33% |
| 2018 FY | 20 Million CHF | 11.11% |
| 2018 Q4 | 20 Million CHF | 0.0% |
| 2018 Q3 | 20 Million CHF | -16.67% |
| 2018 Q2 | 24 Million CHF | 0.0% |
| 2017 FY | 18 Million CHF | 76.47% |
| 2017 Q2 | 25.1 Million CHF | 0.0% |
| 2017 Q4 | 18 Million CHF | 0.0% |
| 2017 Q3 | 18 Million CHF | -28.29% |
| 2017 Q1 | 25.1 Million CHF | 146.08% |
| 2016 Q1 | 26.2 Million CHF | 30.35% |
| 2016 Q3 | 10.2 Million CHF | -61.07% |
| 2016 Q4 | 10.2 Million CHF | 0.0% |
| 2016 Q2 | 26.2 Million CHF | 0.0% |
| 2016 FY | 10.2 Million CHF | -49.25% |
| 2015 Q3 | 20.1 Million CHF | 32.24% |
| 2015 Q1 | 15.2 Million CHF | -49.67% |
| 2015 Q4 | 20.1 Million CHF | 0.0% |
| 2015 FY | 20.1 Million CHF | -33.44% |
| 2015 Q2 | 15.2 Million CHF | 0.0% |
| 2014 Q1 | 47.5 Million CHF | -22.26% |
| 2014 FY | 30.2 Million CHF | -50.57% |
| 2014 Q4 | 30.2 Million CHF | 30.74% |
| 2014 Q2 | 47.5 Million CHF | 0.0% |
| 2014 Q3 | 23.1 Million CHF | -51.37% |
| 2013 Q2 | 77 Million CHF | 0.0% |
| 2013 Q1 | 77 Million CHF | -26.25% |
| 2013 FY | 61.1 Million CHF | -41.48% |
| 2013 Q4 | 61.1 Million CHF | 0.0% |
| 2013 Q3 | 61.1 Million CHF | -20.65% |
| 2012 Q2 | 106.1 Million CHF | 0.0% |
| 2012 Q4 | 104.4 Million CHF | 0.0% |
| 2012 FY | 104.4 Million CHF | 496.57% |
| 2011 Q2 | 37.6 Million CHF | 0.0% |
| 2011 Q4 | 17.5 Million CHF | 0.0% |
| 2011 FY | 17.5 Million CHF | -76.7% |
| 2010 Q4 | 75.1 Million CHF | 0.0% |
| 2010 Q2 | 75.1 Million CHF | 0.0% |
| 2010 FY | 75.1 Million CHF | -25.05% |
| 2009 Q4 | 100.2 Million CHF | 0.0% |
| 2009 FY | 100.2 Million CHF | -47.37% |
| 2008 FY | 190.4 Million CHF | 6.01% |
| 2007 FY | 179.6 Million CHF | 179500.0% |
| 2006 FY | 100 Thousand CHF | -99.94% |
| 2005 FY | 159.1 Million CHF | -38.71% |
| 2004 FY | 259.6 Million CHF | 0.0% |
| 2003 FY | - CHF | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Achiko AG | 2.55 Million USD | 100.0% |
| Accelera Innovations, Inc | - USD | NaN% |
| Aspyra Inc. | 3.6 Million USD | 100.0% |
| Cannabis Sativa, Inc. | 290.22 Thousand USD | 100.0% |
| CompuMed, Inc. | 392.97 Thousand USD | 100.0% |
| CompuGroup Medical SE & Co. KGaA | 846.5 Million USD | 100.0% |
| Cogstate Limited | 672.72 Thousand USD | 100.0% |
| CareView Communications, Inc. | 21.02 Million USD | 100.0% |
| Craneware plc | 35.37 Million USD | 100.0% |
| Caduceus Software Systems Corp. | 2.42 Million USD | 100.0% |
| Certive Solutions Inc. | 5.75 Million USD | 100.0% |
| Drug Free Solution, Inc. | - USD | NaN% |
| DATATRAK International, Inc. | 267.41 Thousand USD | 100.0% |
| Strainsforpains, Inc. | 1.93 Million USD | 100.0% |
| Healixa Inc. | 6.59 Million USD | 100.0% |
| Easy Technologies Inc. | - USD | NaN% |
| eWellness Healthcare Corporation | - USD | NaN% |
| Founders Bay Holdings | - USD | NaN% |
| Health Discovery Corporation | - USD | NaN% |
| Healthcare Integrated Technologies, Inc. | 635.2 Thousand USD | 100.0% |
| H-Source Holdings Ltd. | - USD | NaN% |
| InterCare DX, Inc. | 5062.89 USD | 100.0% |
| iCoreConnect Inc. | 7.87 Million USD | 100.0% |
| IQ-AI Limited | - USD | NaN% |
| Cannabiz Mobile, Inc. | 494.05 Thousand USD | 100.0% |
| Mednow Inc. | 6 Million USD | 100.0% |
| Galileo Life Sciences, Inc. | 20 Thousand USD | 100.0% |
| MediXall Group, Inc. | 2.82 Million USD | 100.0% |
| Mitesco, Inc. | 1.76 Million USD | 100.0% |
| MobileSmith, Inc. | 5.43 Million USD | 100.0% |
| NantHealth, Inc. | 267.4 Million USD | 100.0% |
| Net Medical Xpress Solutions, Inc. | 949 Thousand USD | 100.0% |
| OneLife Technologies Corp. | - USD | NaN% |
| ORHub, Inc. | 8.53 Million USD | 100.0% |
| Patient Access Solutions, Inc. | 925.37 Thousand USD | 100.0% |
| Pharma-Bio Serv, Inc. | 346.5 Thousand USD | 100.0% |
| PPJ Healthcare Enterprises, Inc. | 2.59 Million USD | 100.0% |
| Medical Cannabis Payment Solutions, Inc. | 857.76 Thousand USD | 100.0% |
| Renalytix Plc | 8.53 Million USD | 100.0% |
| Revium Recovery Inc. | 1000.00 USD | 100.0% |
| RYAH Group, Inc. | - USD | NaN% |
| Carepay Inc. | 27.55 Thousand USD | 100.0% |
| Vaso Corporation | 2.06 Million USD | 100.0% |
| Vynleads, Inc. | 527.8 Thousand USD | 100.0% |